alpine antiviral seeks funding of € 1 Mio to conduct PoC experiments in animals.
A total of € 10 Mio is neccessary to complete preclinical studies and initiate Phase 1 clinical studies
Alpine-Antiviral_non-conf-2021PDF Embedder requires a url attribute PDF Embedder requires a url attribute